Skelaxin

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

27 Suppliers, 20 USDMF, 1 EU WC, 14 NDC API, 13 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

1 Suppliers

1 Suppliers

DOSSIERs // Finished Dosage Forms

13 Dossiers, 12 FDA Orange Book, 1 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 800MG

RELATED EXCIPIENT COMPANIES

Suppliers, 29 Kerry, 19 Roquette, 19 BASF, 17 Microlex e.U, 11 Corel Pharma Chem, 10 Sigachi Industries, 9 Gangwal Healthcare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 SPI Pharma, 7 Gangwal Chemicals, 7 Seppic, 6 Ideal Cures Pvt Ltd, 6 Lonza Capsugel, 6 Boai NKY Pharmaceuticals Ltd, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 DFE Pharma, 4 Kima Chemical, 4 Pharmatrans-Sanaq, 4 Prachin Chemical, 3 Alcedo Pharmachem, 3 Vasa Pharmachem, 3 Ingredion Pharma Solutions, 3 DKSH, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Rochem International Inc, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Chynops Pharma, 1 Minakem, 1 Huzhou Sunflower Pharmaceutical, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Nanjing Well Pharmaceutical, 1 Jai Radhe Sales, 1 ACG Worldwide, 1 Qualicaps, 1 Aeon Procare, 1 NEWEDGE Overseas

EXCIPIENTS BY APPLICATIONS

71 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 35 Direct Compression, 30 Controlled & Modified Release, 26 Lubricants & Glidants, 24 Disintegrants & Superdisintegrants, 23 Granulation, 20 Thickeners and Stabilizers, 16 Film Formers & Plasticizers, 14 Solubilizers, 12 Co-Processed Excipients, 11 Taste Masking, 10 Chewable & Orodispersible Aids, 6 API Stability Enhancers, 6 Emulsifying Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Rheology Modifiers, 3 Topical, 3 Parenteral, 2 Coloring Agents

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

2 US Medicaid Prescriptions

MARKET PLACE

4 APIs

4 APIs

PATENTS

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

1 BioAnalytical Methods, 3 USP, 4 Others

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 6 News

Information, Expiry & Status of FDA Orange Book Patents covering Skelaxin

Skelaxin

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

27 Suppliers

20 USDMF

1 EU WC

14 NDC API

13 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

INTERMEDIATES

1 Suppliers

DOSSIERs // Finished Dosage Forms

13 Dossiers

12 FDA Orange Book

1 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 800MG

RELATED EXCIPIENT COMPANIES

Suppliers

29 Kerry

19 Roquette

19 BASF

17 Microlex e.U

11 Corel Pharma Chem

10 Sigachi Industries

9 Gangwal Healthcare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

8 SPI Pharma

7 Gangwal Chemicals

7 Seppic

6 Ideal Cures Pvt Ltd

6 Lonza Capsugel

6 Boai NKY Pharmaceuticals Ltd

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 DFE Pharma

4 Kima Chemical

4 Pharmatrans-Sanaq

4 Prachin Chemical

3 Alcedo Pharmachem

3 Vasa Pharmachem

3 Ingredion Pharma Solutions

3 DKSH

3 The Dow Chemical Company

2 Ulanqab Kema New Material

2 Rochem International Inc

1 Qianhao Chemical (Hebei) Co., Ltd

1 Chynops Pharma

1 Minakem

1 Huzhou Sunflower Pharmaceutical

1 Shanghai Welltone Material Technology Co., Ltd

1 Nanjing Well Pharmaceutical

1 Jai Radhe Sales

1 ACG Worldwide

1 Qualicaps

1 Aeon Procare

1 NEWEDGE Overseas

EXCIPIENTS BY APPLICATIONS

71 Fillers, Diluents & Binders

52 Coating Systems & Additives

35 Direct Compression

30 Controlled & Modified Release

26 Lubricants & Glidants

24 Disintegrants & Superdisintegrants

23 Granulation

20 Thickeners and Stabilizers

16 Film Formers & Plasticizers

14 Solubilizers

12 Co-Processed Excipients

11 Taste Masking

10 Chewable & Orodispersible Aids

6 API Stability Enhancers

6 Emulsifying Agents

5 Empty Capsules

TABLET;ORAL - 400MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons